Search
01/01/2023
Association between dose of catecholamines and markers of organ injury early after out-of-hospital cardiac arrest.
Czerwinska-Jelonkiewicz K, Wood A, Bohm A, Kwasiborski P, Oleksiak A, Ryczek R, Grand J, Tavazzi G, Sionis A, Stepinska J. Association between dose of catecholamines and markers of organ injury early after out-of-hospital cardiac arrest.. Cardiology Journal. 2023; 30(6)DOI:10.5603/CJ.a2021.0173. PMID:34967939. IF:2.500(Q2/5D).
01/01/2023
Incidence, associated burden of disease, and healthcare utilisation of prosthetic joint infections due to Staphylococcus aureus in European hospitals. The COMBACTE-NET ARTHR-IS multicentre study.
Espíndola R, Vella V, Benito N, Mur I, Tedeschi S, Zamparini E, Hendriks JGE, Sorlí L, Murillo O, Soldevila L, Scarborough M, Scarborough C, Kluytmans J, Ferrari MC, Pletz MW, McNamara I, Escudero-Sanchez R, Arvieux C, Batailler C, Dauchy FA, Liu WY, Lora-Tamayo J, Praena J, Ustianowski A, Cinconze E, Pellegrini M, Bagnoli F, Rodríguez-Baño J, Dolores Del Toro M. Incidence, associated burden of disease, and healthcare utilisation of prosthetic joint infections due to Staphylococcus aureus in European hospitals. The COMBACTE-NET ARTHR-IS multicentre study.. JOURNAL OF HOSPITAL INFECTION. 2023; 142DOI:10.1016/j.jhin.2023.09.012. PMID:37797656. IF:3.900(Q1/2D).
01/01/2023
Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial.
Grillo S, Pujol M, Miró JM, López-Contreras J, Euba G, Gasch O, Boix-Palop L, Garcia-País MJ, Pérez-Rodríguez MT, Gomez-Zorrilla S, Oriol I, López-Cortés LE, Pedro-Botet ML, San-Juan R, Aguado JM, Gioia F, Iftimie S, Morata L, Jover-Sáenz A, García-Pardo G, Loeches B, Izquierdo-Cárdenas Á, Goikoetxea AJ, Gomila-Grange A, Dietl B, Berbel D, Videla S, Hereu P, Padullés A, Pallarès N, Tebé C, Cuervo G, Carratalà J. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial.. NATURE MEDICINE. 2023; 29(10)DOI:10.1038/s41591-023-02569-0. PMID:37783969. IF:58.700(Q1/1D).
01/01/2023
Validation of gout diagnosis in electronic primary care medical records: A population-based study.
Pou MA, Martinez-Laguna D, Estebanez JL, Aivar M, Gayarre R, Conesa A, Hoyo J, Carbonell C, Reyes C, Diaz-Torne C. Validation of gout diagnosis in electronic primary care medical records: A population-based study.. JOINT BONE SPINE. 2023; 90(6)DOI:10.1016/j.jbspin.2023.105628. PMID:37634875. IF:3.800(Q1/3D).
01/01/2023
Validation of the algorithm for the monitoring and control of asthma through telemedicine. The Consensus COMETA Project.
Almonacid Sánchez C, Blanco-Aparicio M., Domínguez-Ortega J., Giner Donaire J, Molina Paris J, Sánchez Marcos N, Plaza V.. Validation of the algorithm for the monitoring and control of asthma through telemedicine. The Consensus COMETA Project.. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(3)DOI:10.18176/jiaci.0841. PMID:35797114. IF:6.700(Q1/2D).
01/01/2023
A Longitudinal Clinical Trajectory Analysis Examining the Accumulation of Co-morbidity in People with Type 2 Diabetes (T2D) Compared with Non-T2D Individuals.
Heald A, Qin R, Williams R, Warner-Levy J, Narayanan RP, Fernandez I, Peng Y, Gibson JM, McCay K, Anderson SG, Ollier W. A Longitudinal Clinical Trajectory Analysis Examining the Accumulation of Co-morbidity in People with Type 2 Diabetes (T2D) Compared with Non-T2D Individuals.. Diabetes Therapy. 2023; 14(11)DOI:10.1007/s13300-023-01463-9. PMID:37707702. IF:2.800(Q3/6D).
01/01/2023
Participants' satisfaction with colorectal cancer screening programs: A systematic review.
Selva A, Mosconi G, Cacitti S, Odone A, Pylkkanen L, Solà I, Torà N, Russo S, Cadum E, Deandrea S. Participants' satisfaction with colorectal cancer screening programs: A systematic review.. PREVENTIVE MEDICINE. 2023; 175DOI:10.1016/j.ypmed.2023.107706. PMID:37722458. IF:4.300(Q1/2D).
01/01/2023
Prepandemic personal concentrations of per- and polyfluoroalkyl substances (PFAS) and other pollutants: Specific and combined effects on the incidence of COVID-19 disease and SARS-CoV-2 infection.
Pumarega J, Gasull M, Koponen J, Campi L, Rantakokko P, Henríquez-Hernández LA, Aguilar R, Donat-Vargas C, Zumbado M, Villar-García J, Rius C, Santiago-Díaz P, Vidal M, Jimenez A, Iglesias M, Dobaño C, Moncunill G, Porta M. Prepandemic personal concentrations of per- and polyfluoroalkyl substances (PFAS) and other pollutants: Specific and combined effects on the incidence of COVID-19 disease and SARS-CoV-2 infection.. ENVIRONMENTAL RESEARCH. 2023; 237(Pt 2)DOI:10.1016/j.envres.2023.116965. PMID:37652221. IF:7.700(Q1/1D).